Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 14, 2008

Stroke. 2008
Published online before print February 14, 2008, doi: 10.1161/STROKEAHA.107.499723
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/4/1397    most recent
STROKEAHA.107.499723v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Schryver, E. L.L.M.
Right arrow Articles by van Gijn, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Schryver, E. L.L.M.
Right arrow Articles by van Gijn, J.
Related Collections
Right arrow Secondary prevention
Right arrow Platelet function inhibitors
Right arrow Antiplatelets

Submitted on July 19, 2007
Accepted on July 31, 2007

Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease. An Update

Els L.L.M. De Schryver MD; Ale Algra MD*; and Jan van Gijn MD, FRCP, FRCPE

From the Department of Neurology (E.L.L.M.D.S.), Rijnland Ziekenhuis Leiderdorp, the Netherlands; Julius Center for Health Sciences and Primary Care (A.A.), University Medical Center Utrecht, the Netherlands; Department of Neurology (A.A., J.v.G.), University Medical Center Utrecht, the Netherlands.

* To whom correspondence should be addressed. E-mail: A.Algra{at}umcutrecht.nl.


Key words: dipyridamole • prevention • review • stroke • vascular disease